Browsing: secures

Landmark deal lifts US tariffs on UK medicines, advancing access to innovation and encouraging investment in longevity drugs. Tens of…

MitoRx raises new funding to advance Myo-004, a first-in-class mitochondrial-targeted obesity treatment that aims to preserve lean mass. Oxford-based biotechnology…

Doctor-founded women’s health supplement brand Perelel has netted a US$27 million investment to boost its clinically proven products designed to…

New funding signals growing seriousness in pet longevity science as the field sharpens its claws on translational potential. The Cat…

MH002 is aimed at treating those with mild-to-moderate ulcerative colitis. Credit: Jo Panuwat D/Shutterstock.com. Belgium’s MRM Health has concluded a…